RxDoctor Payments Data

Gala Henson, MD

Family Medicine · Charlotte, NCNPI 1033122288

Payments from drug & device makers

$957in general payments, 2019–2025

Across 25 payments — averaging $38.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$440
  • GSK$115
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$113
  • Johnson & Johnson$108
  • Lilly USA, LLC$75
  • Exact Sciences$63
  • plus $43 from 2 others

What the payments were for

  • Food & beverage$957100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$957 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$2,669
Medicare patients
16
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide54$53,988
OzempicSemaglutide30$35,627
JardianceEmpagliflozin20$20,850
JanuviaSitagliptin Phosphate24$18,950
XareltoRivaroxaban16$12,845
EliquisApixaban13$9,875
Tresiba Flextouch U-100Insulin Degludec12$6,004
Tresiba Flextouch U-200Insulin Degludec14$4,053
Varenicline Tartrate11$2,973
Amlodipine-AtorvastatinAmlodipine/Atorvastatin15$2,872
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,803
SymbicortBudesonide/Formoterol Fumarate15$1,666
Albuterol Sulfate HfaAlbuterol Sulfate79$1,636
Droplet Pen NeedlePen Needle, Diabetic11$1,252
Fluticasone Propionate82$1,003

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$75$53,98854 claims
Novo NordiskOzempic$440$35,62730 claims
MerckJanuvia$23$18,95024 claims
Johnson & JohnsonXarelto$108$12,84516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →